Clinical overview of metronomic chemotherapy in breast cancer | Nature Reviews Clinical Oncology
Metronomic chemotherapy from rationale to clinical studies: A dream or reality? - ScienceDirect
Antibody–drug conjugates, cancer immunotherapy, and metronomic chemotherapy as novel approaches in cancer management
Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion | PLOS ONE
Different chemotherapy regimens. Metronomic chemotherapy regimens... | Download Scientific Diagram
Metronomic Chemotherapy: Direct Targeting of Cancer Cells after all?: Trends in Cancer
Metronomics: towards personalized chemotherapy? | Nature Reviews Clinical Oncology
Chapter 24.3 metronomic chemotherapy
Metronomic Chemotherapy FAQs for Tripawds
Metronomic chemotherapy: An attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance - ScienceDirect
Metronomic and metronomic-like therapies in neuroendocrine tumors – Rationale and clinical perspectives - ScienceDirect
JCM | Free Full-Text | Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows | HTML
Metronomic chemotherapy: an attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance. - Abstract - Europe PMC
Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial - The Lancet Global Health
Metronomic Chemotherapy: New Rationale for New Directions
Chrono Modulation and Metronomic Dosing - ZenOnco.io
JCM | Free Full-Text | Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical Studies
Metronomic chemotherapy offsets HIFα induction upon maximum‐tolerated dose in metastatic cancers | EMBO Molecular Medicine
Frontiers | Sustained Complete Response to Metronomic Chemotherapy in a Child with Refractory Atypical Teratoid Rhabdoid Tumor: A Case Report
Metronomic chemotherapy: new rationale for new directions | Nature Reviews Clinical Oncology
A phase 1/2 study of metronomic 5-fluorouracil (5-FU) plus nab-paclitaxel, bevacizumab, leucovorin, and oxaliplatin (FABLOx) in patients with metastatic pancreatic cancer - Annals of Oncology
Metronomic Maintenance Therapy for Rhabdomyosarcoma: Trends in Cancer
Metronomic Chemotherapy: Pharmacology and Clinical Applications: 9783662436035: Medicine & Health Science Books @ Amazon.com
Metronomic chemotherapy using orally active carboplatin/deoxycholate complex to maintain drug concentration within a tolerable range for effective cancer management - ScienceDirect
Metronomic Chemotherapy - Ethos Veterinary Health
